Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Executed Contract with HMRC for Vaping Duty Stamps

5 Feb 2026 07:00

RNS Number : 7858R
Spectra Systems Corporation
05 February 2026
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

5, February 2026

Spectra Systems Corporation

Executed Contract with HMRC for Vaping Duty Stamps Scheme

Further to the RNS dated 16 January 2026, Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, security printing, brand protection technologies and gaming security software, is pleased to announce that its security printing arm, Cartor Security Printers ("CSP"), has executed the contract with HMRC for production and supply of vape duty stamps. CSP was the primary on the contract, which was submitted in partnership with SICPA SA, a world leader in tax stamp track and trace technology.

The total estimated contract value is estimated to be £32M ($43.8M) excluding VAT and is based on five years and has an option for an additional year. Under the finalized executed contract terms, Spectra will be providing additional services and now expects its portion of the contract value to be approximately 22% of the total five-year revenue. As the lead in the contract, Spectra will be receiving entire $43.8M of revenue and dispersing the funds accordingly. Within the CSP-led consortium, CSP will be responsible for production and supply of stamps as well as high level forensic authentication features and associated devices provided by Spectra in Rhode Island, USA. Our partner will be responsible for additional security features, tax stamp coding, along with the track and trace software solution, managing stakeholder and product registration, tax stamp ordering, making payments and collecting data and monitoring compliance for HMRC relating to the vape products' entire journey through the supply chain.

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "We are delighted to have finalized this important new contract as we continue our re-organization of the security printing business to boost profits through longer term contracts. With the first phase of the reorganization having been completed in the UK facility, we are confident that with, this new prestigious contract win, we expect to see significant profits from CSP in 2026 and more so in 2027 when the entire benefit of the restructuring is in full operation."

The person responsible for arranging the release of this announcement on behalf of the Company is Dr. Nabil Lawandy, Chief Executive Officer of the Company.

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

Zeus (Nominated Adviser and Joint Broker)

James Joyce / James Bavister/ Andrew de Andrade (Investment Banking)

 

 Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 5000

 

 

 

Tel: +44 (0)20 3328 5665

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFZLLBQLLXBBQ
Date   Source Headline
5th Jan 20214:02 pmRNSDirectorate
5th Jan 20217:00 amRNSShare Buy-Back
14th Dec 20207:01 amRNSTwo Lottery Renewals
14th Dec 20207:00 amRNSAcquisition of interest - Solaris BioSciences, Inc
21st Oct 20209:06 amRNSSecond Price Monitoring Extn
21st Oct 20209:01 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSContract with a Central Bank
14th Oct 20205:27 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSRemoval of Regulation S Restrictions
11th Sep 20204:34 pmRNSExercise of Options and Director/PDMR Shareholding
10th Sep 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
7th Sep 20207:00 amRNSInterim Results for the Six Months 30 June 20
25th Aug 20204:11 pmRNSHolding(s) in Company
15th Jul 20206:25 pmRNSDirector Dealings
9th Jul 20207:00 amRNSContract with a Major Central Bank
26th Jun 20207:00 amRNSShare Buy-Back
25th Jun 20207:00 amRNSShare Buy-Back and Removal of Reg S Restrictions
16th Jun 20203:23 pmRNSShare Buy-Back
10th Jun 20207:00 amRNSAsian Central Bank Contract Update
26th May 20207:00 amRNSDirector Dealings
15th May 20205:24 pmRNSExercise of Options and Removal of Regulation S
30th Apr 20208:51 amRNSPosting of Annual Report and Accounts
3rd Apr 20204:56 pmRNSShare Buy-Back and Removal of Reg S Restrictions
23rd Mar 202012:37 pmRNSAudited Results
16th Mar 20201:59 pmRNSHolding(s) in Company
9th Mar 20204:41 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSShare Buy-Back
11th Nov 20193:30 pmRNSHolding(s) in Company
30th Oct 20191:39 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSHolding(s) in Company
25th Sep 20192:59 pmRNSHolding(s) in Company
24th Sep 20197:00 amRNSInterim Results
17th Sep 20197:00 amRNSFunding Approval - G7 Central Bank
1st Aug 20197:00 amRNSPolymer Banknote Substrate Supply Agreement
15th Jul 20197:00 amRNSNew Lottery Security Contracts
24th Jun 20197:00 amRNSAnnual General Meeting Lack of Quorum
11th Jun 20197:00 amRNSFive Year Optical Materials Supply Contract
29th May 20194:12 pmRNSExercise of Options
29th May 20197:00 amRNSTrading Update
28th May 20197:00 amRNSRemoval of Regulation S restrictions from shares
17th May 20193:21 pmRNSRemoval of Regulation S restrictions from shares
10th May 20192:31 pmRNSPosting of AGM Notice
10th May 20192:15 pmRNSShare Buy-Back
26th Apr 20198:55 amRNSPosting of Annual Report and Accounts
24th Apr 20197:00 amRNSRemoval of Regulation S Restrictions from Stock
18th Apr 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
15th Apr 20197:00 amRNSUpdated CEO Employment Agreement
10th Apr 20197:00 amRNSShare Buy-Back Programme
25th Mar 20197:00 amRNSPreliminary Results
18th Mar 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.